Arup G, Shravan N (2023) Cancer and Pregnancy in the Post-Roe v. Wade Era: A Comprehensive Review. Curr Oncol 30(11):9448–9457. https://doi.org/10.3390/curroncol30110684
Article PubMed PubMed Central Google Scholar
Barber Hugh RK (2001) Malignant disease in pregnancy. J Perinat Med 29(2):97–111. https://doi.org/10.1515/JPM.2001.014
Mazzola R, Corradini S, Eidemüeller M, Figlia V, Fiorentino A, Giaj-Levra N, Nicosia L, Ricchetti F, Rigo M, Musola M, Ceccaroni M, Gori S, Magrini SM, Alongi F (2019) Modern radiotherapy in cancer treatment during pregnancy. Crit Rev Oncol Hematol 136:13–19. https://doi.org/10.1016/j.critrevonc.2019.02.002
Pavlidis NA (2002) Coexistence of Pregnancy and Malignancy. The Oncol 7(4):279–287. https://doi.org/10.1634/theoncologist.2002-0279
Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: Poena magna, not anymore. Eur J Cancer 42(2):126–140. https://doi.org/10.1016/j.ejca.2005.10.014
Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, Girinsky T, Hoppe RT, Mauch P, Mikhaeel NG, Ng A (2014) Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys 89(4):854–862. https://doi.org/10.1016/j.ijrobp.2013.05.005
Eich HT, Pepper NB, Oertel M (2023) Evolution of Radiation Fields from Involved Field to Involved Site—A Summary of the Current Guidelines by the International Lymphoma Radiation Oncology Group. Lymphatics 1(3):262–272. https://doi.org/10.3390/lymphatics1030017
Kumar R, De Jesus O (2023) Radiation Effects On The Fetus. Treasure. Island, (FL), StatPearls Publishing
Fenig E, Mishaeli M, Kalish Y, Lishner M (2001) Pregnancy and radiation. Cancer Treat Rev 27(1):1–7. https://doi.org/10.1053/ctrv.2000.0193
Article CAS PubMed Google Scholar
Kal HB, Struikmans H (2005) Radiotherapy during pregnancy: Fact and fiction. Lancet Oncol 6(5):328–333. https://doi.org/10.1016/S1470-2045(05)70169-8
Giacomuzzi SM, Torbica P, Rieger M, Lottersberger C, Peer S, Peer R, Perkmann R, Buchberger W, Bale R, Mallouhi A, Jaschke W (2001) Radiation exposure in single slice and multi-slice spiral CT (a phantom study). Rofo 173(7):643–649. https://doi.org/10.1055/s-2001-15831
Article CAS PubMed Google Scholar
Schlegel W, Karger CP, Jäkel O (2018) Medizinische Physik Grundlagen-Bildgebung-Therapie-Technik. In. Springer Spektrum, Heidelberg, pp 486–509
Wirth A, Mikhaeel NG, Aleman BMP, Pinnix CC, Constine LS, Ricardi U, Illidge TM, Eich HT, Hoppe BS, Dabaja B, Ng AK, Kirova Y, Berthelsen AK, Dieckmann K, Yahalom J, Specht L (2020) Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines. Int J Radiat Oncol Biol Phys 107(5):909–933. https://doi.org/10.1016/j.ijrobp.2020.03.019
Purdy JA (2004) Current ICRU Definitions of Volumes: Limitations and Future Directions. Semin Radiat Oncol 14(1):27–40. https://doi.org/10.1053/j.semradonc.2003.12.002
International Commission on Radiation Units and Measurements (ICRU) (1993) Prescribing, Recording, and Reporting Photon Beam Therapy. Washington, DC. https://www.icru.org/report/prescribing-recording-and-reporting-photon-beam-therapy-report-50/
International Commission on Radiation Units and Measurements (ICRU) (1999) Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU 50). Washington, DC. https://www.icru.org/report/prescribing-recording-and-reporting-photon-beam-therapy-report-62/
Leitlinienprogramm Onkologie, Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2022) S3-Leitlinie Diagnostik, Therapie und Nachsorge des Hodgkin Lymphoms bei erwachsenen Patienten, Langversion 3.2. https://www.leitlinienprogramm-onkologie.de/leitlinien/hodgkin-lymphom/ (Accessed 13 Sept 2024)
United Nations Scientific Committee on the Effects of Atomic Radiation (2000). https://www.unscear.org/docs/publications/2000/UNSCEAR_2000_Report_Vol.I.pdf (Accessed 2 March 2024)
Valentin J (2003) Biological effects after prenatal irradiation (embryo and fetus). Icrp Publ 33(1–2):125–139. https://doi.org/10.1016/S0146-6453(03)00021-6
Eichenauer DA, Aleman BMP, André M, Federico M, Hutchings M, Illidge T, Engert A, Ladetto M on behalf oft he ESMO Guidelines Committee (2018) Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‑u. Ann Oncol 29(4):iv19–iv29. https://doi.org/10.1093/annonc/mdy080
Engert A, Franklin J, Eich HT, Brillant C, Sehlen S, Cartoni C, Herrmann R, Pfreundschuh M, Sieber M, Tesch H, Franke A, Koch P, de Wit M, Paulus U, Hasenclever D, Loeffler M, Müller R‑P, Müller-Hermelink HK, Dühmke E, Diehl V (2007) J Clin Oncol 25(23):3495–3502. https://doi.org/10.1200/JCO.2006.07.0482
Article CAS PubMed Google Scholar
Fermé C et al (2007) Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease. N Engl J Med 357(19):1916–1927. https://doi.org/10.1056/NEJMoa064601
Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5(5):283–291. https://doi.org/10.1016/S1470-2045(04)01466-4
Article CAS PubMed Google Scholar
Radford J, Illidge T, Counsell N, Hancock B, Pettengell R, Johnson P, Wimperis J, Culligan D, Popova B, Smith P, McMillan A, Brownell A, Kruger A, Lister A, Hoskin P, O’Doherty M, Barrington S (2015) Results of a trial of PET-directed therapy for early-stage Hosgkin’s lymphoma. N Engl J Med 372(17):1598–1607. https://doi.org/10.1056/NEJMoa1408648
Article CAS PubMed Google Scholar
Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, Sasse S, Topp MS, Schäfer E, Hertenstein B, Soekler M, Vogelhuber M, Zijlstra JM, Keller UB, Krause SW, Wilhelm M, Maschmeyer G, Thiemer J, Dührsen U, Meissner J, Viardot A, Eich H, Baues C, Diehl V, Rosenwald A, von Tresckow B, Dietlein M, Borchmann P, Engert A (2019) Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. J Clin Oncol 37(31):2835–2845
Eichenauer DA, Plütschow A, Fuchs M, von Tresckow B, Böll B, Behringer K, Diehl V, Eich HAT, Borchmann P, Engert A (2015) Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. J Clin Oncol 33(26):2992–2998. https://doi.org/10.1200/JCO.2014.60.4363
Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, Ng AK, Roberts KB, Gao S, Balogh A, Ricardi U, Levis M, Casulo C, Stolten M, Specht L, Plastaras JP, Wright C, Kelsey CR, Brady JL, Mikhaeel NG, Hoppe BS, Terezakis SA, Picardi M, Pepa DR, Kirova Y, Akhtar S, Maghfoor I, Koenig JL, Jackson C, Song E, Sehgal S, Advani RH, Natkunam Y, Constine LS, Eich HT, Wirth A, Hoppe RT (2020) Stage I–II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. Blood 135(26):2365–2374. https://doi.org/10.1182/blood.2019003877
Mayr NA, Wen BC, Saw CB (1998) Radiation therapy during pregnancy. Obstet Gynaecol Clin North Am 25(2):301–321. https://doi.org/10.1016/s0889-8545(05)70006-1
Bachanova V, Connors JM (2013) Hodgkin lymphoma in pregnancy. Curr Haematol Malig Rep 8(3):211–217. https://doi.org/10.1007/s11899-013-0163-4
Stuschke M, Müller WU (2002) Strahlentherapie in der Schwangerschaft. Onkologe 8:1302–1308. https://doi.org/10.1007/s00761-002-0437-2
Nguyen CP, Goodman LH (2012) Fetal risk in diagnostic radiology. Semin Ultrasound CT MR 33(1):4–10. https://doi.org/10.1053/j.sult.2011.09.003
International Commission on Radiological Protection (2000) Pregnancy and medical radiation. Ann ICRP 30(1):1–43. https://doi.org/10.1016/s0146-6453(00)00037-3
Otake M, Schull WJ, Yoshimaru H (1991) A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Brain Damage Among Prenat Expo J Radiat Res 32:249–264. https://doi.org/10.1269/jrr.32.supplement_249
Doll R, Wakeford R (1997) Risk of childhood cancer from fetal irradiation. Br J Radiol 70:130–139. https://doi.org/10.1259/bjr.70.830.9135438
Article CAS PubMed Google Scholar
Ögretici A, Cakir A, Akbas U, Köksal C, Kalafat Ü, Tambas M, Bilge H (2017) A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment. J Med Phys 42(3):128–132. https://doi.org/10.4103/jmp.JMP_133_16
Comments (0)